Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lymphatic dysfunction as a cause of calcium channel blocker oedema
2012-002622-75Phase 3Completed
- Sponsor
- Vibeke Hjortdal
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of nifedipine in peripheral edema and cardiac morbidity, sponsored by Vibeke Hjortdal. Primary endpoints: Contraction frequency under normal conditions, Contraction wave propagation velocity under normal conditions and 2 more. Started May 2013; status: completed.
02
Drugs
nifedipine
03
Conditions
peripheral edemacardiac morbidity
Beyond the preview
Go deeper on 2012-002622-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002622-75.